Use of Platelet Rich Plasma (PRP) for Improving Thin Endometrium

Ibn Sina Hospital150 enrolled

Overview

Platelets rich plasma is simple source of growth factors and cytokines that can regulate endometrial growth for subgroup of thin endometrium women. It is an autologous source of this enhancing factors; therefore, there os no risk of using it within the same participant.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

SINGLE

Enrollment

150

Conditions

Poor Endometrium

Interventions

Treatment of Thin EndometriumOTHER

This is a trial to improve endometrial thickness by autologous injection of PRP into the Uterine Cavity compared with CSF or no treatment.

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * women with thin endometrium Exclusion Criteria: * serum positive hepatitis B and C women

Locations (2)

Gannah IVF unit, Gannah Hospital

Giza, Egypt

IbnSina IVF Center, IbnSina Hospital

Sohag, Egypt

Outcomes

Primary Outcomes

Mean Diameter of endometrial thickness

How the endometrium would respond after 2 days of PRP

Time frame: 2 days

Secondary Outcomes

Clinical pregnancy rate

Registered fetal heartbeat 4 weeks or beyond after embryo transfer.

Time frame: 4 weeks or beyond after embryo Transfer

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.